Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Korea's Greenhouse Gas Reduction Project Highlights Pharmaceutical Industry As "Clean Growth Sector"

This article was originally published in PharmAsia News

Executive Summary

SEOUL - The South Korean government's goal of adopting a new energy-efficient national growth paradigm following years of energy-intensive economic expansion will benefit local and multiunational pharmaceutical companies operating in Korea, a presidential advisor said

You may also be interested in...

Pharma, Medical Device Provisions Outlined In Korea, EU Free Trade Agreement

SEOUL - South Korea's Ministry of Foreign Affairs and Trade unveiled the content of pharmaceutical and medical device provisions in its Free Trade Agreement with the EU, which was initialed by its Trade Minister Kim Jong-hoon and EU Trade Commissioner Catherine Ashton in Brussels Oct. 15

Industry Groups Make Anti-Kickback Pledge To Korean Health Industry

SEOUL - South Korean trade associations representing both multinational and local pharmaceutical companies told the government that their members will accept the government's new guidelines that classify meals provided to doctors and pharmacists worth more than KRW 100,000 ($80) as illegal kickbacks

Korea Moves To Help Samsung Electronics Create Consortium in Biosimilars

SEOUL - As the South Korean government accelerates its drive to get local producers of biosimilars globally competitive, the Ministry of Knowledge Economy is setting the stage for Samsung Electronics to become a giant in the emerging biosimlars market

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts